Key Takeaways FDA has launched an aggressive new crackdown on direct-to-consumer (DTC) drug advertising, issuing nearly 100 cease-and-desist letters and thousands of notices — many targeting ...

Walmsley, who became CEO of the U.K. drugmaker in 2017 and is due to step down at the end of the year, led GSK through the Covid-19 pandemic, a fight with activist investor Elliott Management, and a ...

The injectable, Lenacapavir, is expected to play a key role in efforts to eliminate HIV, following UNAIDS’ call for countries to end the epidemic amid funding challenges.

Being out of care doesn’t have to be permanent, and many people can restart HIV treatment. The sooner PWH restart treatment, the better, as restarting and staying on HIV treatment can help them reach ...

Cheap generic versions of a groundbreaking HIV-prevention jab should be available in more than 100 countries from 2027, potentially transforming the global fight against the virus.

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...

Florida will get $3 million as part of a nationwide settlement over allegations a drug manufacturer gave kickbacks to doctors.

Two partnerships will provide millions of people access to what is widely described as the most effective HIV prevention drug.

Attorney General James Uthmeier announced on Wednesday that a $3 million settlement agreement with Gilead Sciences, Inc.

A game-changing HIV prevention drug is set to become vastly more affordable in over 100 low- and middle-income countries, a move that could bring the world closer to ending the HIV/AIDS epidemic.

“The idea to process drugs in space isn’t new. Research showing that microgravity can impact crystallization has been done on the ISS for decades,” said Radocea. “However, when reusable rockets made ...